This website or its third party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the cookie policy. By closing this banner you agree to the use of cookies.

Technical Statistical Marketing

Show preferences Accept all

Monday, January 12th, 2015 - General News

CONTINUUS awarded SBIR Phase I grant from the NSF

CONTINUUS Pharmaceuticals was awarded a Phase I SBIR grant from the National Science Foundation to further develop its breakthrough ICM technology. This Phase I grant consists of $150,000 over a six month period.

Share news

Request Information

Phone: (781) 281-0115 Main Office

Email: [email protected]